Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sight Sciences, Inc.

3.41
-0.0200-0.58%
Volume:111.95K
Turnover:384.52K
Market Cap:176.30M
PE:-3.49
High:3.51
Open:3.39
Low:3.37
Close:3.43
Loading ...

Paul Badawi, President and CEO, Reports Disposal of Common Shares of Sight Sciences Inc

Reuters
·
08 Jul

CFO Alison Bauerlein Reports Disposal of Common Shares in Sight Sciences Inc

Reuters
·
08 Jul

Matthew Link, Chief Commercial Officer, Reports Disposal of Common Shares in Sight Sciences Inc

Reuters
·
08 Jul

Sight Sciences Is Maintained at Neutral by Piper Sandler

Dow Jones
·
18 Jun

Piper Sandler Reaffirms Their Hold Rating on Sight Sciences (SGHT)

TIPRANKS
·
18 Jun

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sight Sciences (SGHT) and Cullinan Management (CGEM)

TIPRANKS
·
17 Jun

Sight Sciences: Hold Rating Amid Promising TearCare Potential and Market Access Challenges

TIPRANKS
·
17 Jun

Sight Sciences Holds Annual Stockholders Meeting

TIPRANKS
·
06 Jun

Sight Sciences Inc. Conducted Annual Stockholders Meeting

Reuters
·
06 Jun

Director and 10% Owner Staffan Encrantz Reports Acquisition of Common Shares in Sight Sciences Inc

Reuters
·
04 Jun

Director and 10% Owner Staffan Encrantz Reports Acquisition of Sight Sciences Common Shares

Reuters
·
30 May

Sight Sciences Is Maintained at Neutral by Citigroup

Dow Jones
·
23 May

CFO Alison Bauerlein Reports Disposal of Common Shares of Sight Sciences Inc

Reuters
·
22 May

Piper Sandler Sticks to Its Hold Rating for Sight Sciences (SGHT)

TIPRANKS
·
09 May

Sight Sciences Is Maintained at Hold by Lake Street

Dow Jones
·
09 May

Sight Sciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

Sight Sciences Reports Q1 2025 Financial Results

TIPRANKS
·
09 May

Sight Sciences Q1 EPS $(0.28) Beats $(0.30) Estimate, Sales $17.51 Miss $16.51M Estimate

Benzinga
·
09 May

Press Release: Sight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue Guidance

Dow Jones
·
09 May

BRIEF-Sight Sciences Q1 Revenue USD 17.5 Million Vs. IBES Estimate USD 16.5 Million

Reuters
·
09 May